Phase Ib evaluation of a self-adjuvanted protamine formulated mRNA-based active cancer immunotherapy, BI1361849 (CV9202), combined with local radiation treatment in patients with stage IV non-small cell lung cancer

Alexandros Papachristofilou, M. Hipp, Ute Klinkhardt, Martin Früh, Martin Sebastian, Miklos Pless, Richard Cathomas, Wolfgang Hilbe, Georg Pall, Thomas Wehler,

Journal for ImmunoTherapy of Cancer · 2019 · 213 citations · 34 references

DOIFull text

Open access

Abstract

ClinicalTrials.gov identifier: NCT01915524 .

References

34